[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE383156T1 - Oral verabreichbare zusammensetzung enthaltend parecoxib - Google Patents

Oral verabreichbare zusammensetzung enthaltend parecoxib

Info

Publication number
ATE383156T1
ATE383156T1 AT02789593T AT02789593T ATE383156T1 AT E383156 T1 ATE383156 T1 AT E383156T1 AT 02789593 T AT02789593 T AT 02789593T AT 02789593 T AT02789593 T AT 02789593T AT E383156 T1 ATE383156 T1 AT E383156T1
Authority
AT
Austria
Prior art keywords
composition containing
oral composition
parecoxib
containing parecoxib
oral
Prior art date
Application number
AT02789593T
Other languages
English (en)
Inventor
Aziz Karim
Sandeep Nema
Gary Ewing
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE383156T1 publication Critical patent/ATE383156T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02789593T 2001-11-13 2002-11-12 Oral verabreichbare zusammensetzung enthaltend parecoxib ATE383156T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35059601P 2001-11-13 2001-11-13

Publications (1)

Publication Number Publication Date
ATE383156T1 true ATE383156T1 (de) 2008-01-15

Family

ID=23377399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02789593T ATE383156T1 (de) 2001-11-13 2002-11-12 Oral verabreichbare zusammensetzung enthaltend parecoxib

Country Status (20)

Country Link
US (1) US20030100595A1 (de)
EP (1) EP1446118B1 (de)
JP (1) JP2005509002A (de)
KR (1) KR20050044459A (de)
CN (1) CN1615135A (de)
AR (1) AR037356A1 (de)
AT (1) ATE383156T1 (de)
BR (1) BR0214081A (de)
CA (1) CA2466504A1 (de)
CO (1) CO5580744A2 (de)
DE (1) DE60224558T2 (de)
ES (1) ES2297032T3 (de)
IL (1) IL161991A0 (de)
MX (1) MXPA04004476A (de)
NO (1) NO20042440L (de)
PL (1) PL369962A1 (de)
RU (1) RU2004114552A (de)
TW (1) TW200300680A (de)
WO (1) WO2003041705A1 (de)
ZA (1) ZA200403328B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785640B2 (en) 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
ME02746B (de) 2004-10-08 2018-01-20 Forward Pharma As Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
US7964223B2 (en) * 2005-09-27 2011-06-21 University Of Kentucky Research Foundation Berry preparations and extracts
WO2007042035A2 (en) * 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
WO2008027037A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
PT2209501E (pt) * 2007-10-12 2012-02-03 Astrazeneca Ab Composição de zibotentan contendo manitol e celulose microcristalina
DK2564839T3 (en) 2009-01-09 2016-07-25 Forward Pharma As A pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
JP6102120B2 (ja) * 2012-08-16 2017-03-29 ニプロ株式会社 医薬製剤およびその製造方法
CN104771370B (zh) * 2014-01-14 2020-07-24 南京圣和药业股份有限公司 帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) * 2015-06-11 2016-06-29 成都克莱蒙医药科技有限公司 一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) * 2016-06-21 2018-11-02 马鞍山丰原制药有限公司 一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) * 2020-11-24 2021-02-26 苏州璞正医药有限公司 一种帕瑞昔布衍生物及其制备方法和应用
CN118767141A (zh) * 2023-04-04 2024-10-15 上海汇伦医药股份有限公司 西维来司他用于镇痛的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688510A (en) * 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
IL125849A (en) * 1996-04-12 2003-10-31 Searle & Co Substituted benzenesulfonamide derivatives, their preparation and pharmaceutical compositions comprising them
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
AU8026200A (en) * 1999-10-19 2001-04-30 Board Of Regents, The University Of Texas System Treatment of heart disease with cox-2 inhibitors
AU1930301A (en) * 1999-12-08 2001-06-18 Pharmacia Corporation Valdecoxib compositions
CN1230167C (zh) * 1999-12-22 2005-12-07 法马西亚公司 环加氧酶－2抑制剂的二元释放组合物
CA2402436C (en) * 2000-03-24 2010-02-16 Pharmacia Corporation Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
AU2001282886A1 (en) * 2000-07-13 2002-01-30 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition

Also Published As

Publication number Publication date
PL369962A1 (en) 2005-05-02
DE60224558T2 (de) 2009-01-22
CO5580744A2 (es) 2005-11-30
TW200300680A (en) 2003-06-16
CN1615135A (zh) 2005-05-11
EP1446118A1 (de) 2004-08-18
CA2466504A1 (en) 2003-05-22
MXPA04004476A (es) 2004-08-11
ZA200403328B (en) 2005-04-13
IL161991A0 (en) 2005-11-20
WO2003041705A1 (en) 2003-05-22
KR20050044459A (ko) 2005-05-12
EP1446118B1 (de) 2008-01-09
AR037356A1 (es) 2004-11-03
DE60224558D1 (de) 2008-02-21
US20030100595A1 (en) 2003-05-29
ES2297032T3 (es) 2008-05-01
RU2004114552A (ru) 2005-02-20
JP2005509002A (ja) 2005-04-07
NO20042440L (no) 2004-08-09
BR0214081A (pt) 2004-09-28

Similar Documents

Publication Publication Date Title
PL365518A1 (en) Oral composition
DE60143252D1 (de) Dentalklebstoffzusammensetzung
DK1522539T3 (da) Krystallinsk komposition indeholdende excitalopram
ID26720A (id) Komposisi oral
PL1638529T3 (pl) Kompozycja doustna o przedłużonym uwalnianiu
GB0119935D0 (en) Perfume containing composition
IS6915A (is) Lyfjablanda
BR0210619A (pt) composição
PL362435A1 (en) Oral bleaching composition
UY3265Q (es) Cepillo dental
IS7081A (is) Lyfjablanda
DE60214455D1 (de) Dentale Reibahle
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
ATE383156T1 (de) Oral verabreichbare zusammensetzung enthaltend parecoxib
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
GB0126244D0 (en) Oral compositions
DE60223762D1 (de) Zusammensetzung enthaltend Diätfasern
EP1459733A4 (de) Orale zusammensetzung
GB0016067D0 (en) Oral compositions
ATE338460T1 (de) Fungizide zusammensetzungen enthaltend fludioxonil
ATE297187T1 (de) Resorcinenthaltende zusammensetzung
GB0022297D0 (en) Oral compositions
ITTO20020747A0 (it) Composizione
PL377147A1 (pl) Doustna kompozycja
HUP0301891A3 (en) Oral composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties